These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9200012)
1. Specific inhibitors of vacuolar H(+)-ATPase trigger apoptotic cell death of osteoclasts. Okahashi N; Nakamura I; Jimi E; Koide M; Suda T; Nishihara T J Bone Miner Res; 1997 Jul; 12(7):1116-23. PubMed ID: 9200012 [TBL] [Abstract][Full Text] [Related]
2. Increase in Bcl-2 level promoted by CD40 ligation correlates with inhibition of B cell apoptosis induced by vacuolar type H(+)-ATPase inhibitor. Akifusa S; Ohguchi M; Koseki T; Nara K; Semba I; Yamato K; Okahashi N; Merino R; Núñez G; Hanada N; Takehara T; Nishihara T Exp Cell Res; 1998 Jan; 238(1):82-9. PubMed ID: 9457059 [TBL] [Abstract][Full Text] [Related]
3. Specific inhibitors of vacuolar type H(+)-ATPases induce apoptotic cell death. Nishihara T; Akifusa S; Koseki T; Kato S; Muro M; Hanada N Biochem Biophys Res Commun; 1995 Jul; 212(1):255-62. PubMed ID: 7612014 [TBL] [Abstract][Full Text] [Related]
4. Interleukin 1 induces multinucleation and bone-resorbing activity of osteoclasts in the absence of osteoblasts/stromal cells. Jimi E; Nakamura I; Duong LT; Ikebe T; Takahashi N; Rodan GA; Suda T Exp Cell Res; 1999 Feb; 247(1):84-93. PubMed ID: 10047450 [TBL] [Abstract][Full Text] [Related]
5. The regulation of pHi in osteoclasts is dependent on the culture substrate and on the stage of the resorption cycle. Lehenkari PP; Laitala-Leinonen T; Linna TJ; Väänänen HK Biochem Biophys Res Commun; 1997 Jun; 235(3):838-44. PubMed ID: 9207248 [TBL] [Abstract][Full Text] [Related]
6. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Lee SH; Rho J; Jeong D; Sul JY; Kim T; Kim N; Kang JS; Miyamoto T; Suda T; Lee SK; Pignolo RJ; Koczon-Jaremko B; Lorenzo J; Choi Y Nat Med; 2006 Dec; 12(12):1403-9. PubMed ID: 17128270 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of bafilomycin A1 derivatives as inhibitors of vacuolar H+-ATPase. Gagliardi S; Gatti PA; Belfiore P; Zocchetti A; Clarke GD; Farina C J Med Chem; 1998 May; 41(11):1883-93. PubMed ID: 9599238 [TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of vacuolar H(+)-ATPase inhibitors to UMR-106 rat osteoblasts: an effect on iron uptake into cells? Hall TJ Cell Biol Int; 1994 Mar; 18(3):189-93. PubMed ID: 8019493 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 stimulates osteoclast-like cell formation and bone-resorbing activity via osteoblasts: role of cAMP-dependent protein kinase. Kaji H; Sugimoto T; Kanatani M; Fukase M; Kumegawa M; Chihara K J Bone Miner Res; 1996 Jan; 11(1):62-71. PubMed ID: 8770698 [TBL] [Abstract][Full Text] [Related]
11. Role of c-Src in cellular events associated with colony-stimulating factor-1-induced spreading in osteoclasts. Insogna K; Tanaka S; Neff L; Horne W; Levy J; Baron R Mol Reprod Dev; 1997 Jan; 46(1):104-8. PubMed ID: 8981371 [TBL] [Abstract][Full Text] [Related]
12. Enhanced expression of p53 and apoptosis induced by blockade of the vacuolar proton ATPase in cardiomyocytes. Long X; Crow MT; Sollott SJ; O'Neill L; Menees DS; de Lourdes Hipolito M; Boluyt MO; Asai T; Lakatta EG J Clin Invest; 1998 Mar; 101(6):1453-61. PubMed ID: 9502788 [TBL] [Abstract][Full Text] [Related]
13. Bafilomycin A1 induces apoptosis in the human pancreatic cancer cell line Capan-1. Ohta T; Arakawa H; Futagami F; Fushida S; Kitagawa H; Kayahara M; Nagakawa T; Miwa K; Kurashima K; Numata M; Kitamura Y; Terada T; Ohkuma S J Pathol; 1998 Jul; 185(3):324-30. PubMed ID: 9771488 [TBL] [Abstract][Full Text] [Related]
14. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase. David P; Nguyen H; Barbier A; Baron R J Bone Miner Res; 1996 Oct; 11(10):1498-507. PubMed ID: 8889850 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of bone resorption in vitro by antisense RNA and DNA molecules targeted against carbonic anhydrase II or two subunits of vacuolar H(+)-ATPase. Laitala T; Väänänen HK J Clin Invest; 1994 Jun; 93(6):2311-8. PubMed ID: 8200964 [TBL] [Abstract][Full Text] [Related]
16. A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rats with high potency and specificity: potential for clinical application. Niikura K; Takeshita N; Takano M J Bone Miner Res; 2005 Sep; 20(9):1579-88. PubMed ID: 16059630 [TBL] [Abstract][Full Text] [Related]
17. Vacuolar-type H+-ATPase-mediated acidosis promotes in vitro osteoclastogenesis via modulation of cell migration. Kim JM; Min SK; Kim H; Kang HK; Jung SY; Lee SH; Choi Y; Roh S; Jeong D; Min BM Int J Mol Med; 2007 Mar; 19(3):393-400. PubMed ID: 17273786 [TBL] [Abstract][Full Text] [Related]
18. Chemical and physical properties of the extracellular matrix are required for the actin ring formation in osteoclasts. Nakamura I; Takahashi N; Sasaki T; Jimi E; Kurokawa T; Suda T J Bone Miner Res; 1996 Dec; 11(12):1873-9. PubMed ID: 8970888 [TBL] [Abstract][Full Text] [Related]
19. V-ATPases in osteoclasts: structure, function and potential inhibitors of bone resorption. Qin A; Cheng TS; Pavlos NJ; Lin Z; Dai KR; Zheng MH Int J Biochem Cell Biol; 2012 Sep; 44(9):1422-35. PubMed ID: 22652318 [TBL] [Abstract][Full Text] [Related]
20. Specific biological functions of vacuolar-type H(+)-ATPase and lysosomal cysteine proteinase, cathepsin K, in osteoclasts. Sahara T; Itoh K; Debari K; Sasaki T Anat Rec A Discov Mol Cell Evol Biol; 2003 Feb; 270(2):152-61. PubMed ID: 12524690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]